FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss| U.S. Food and Drug Administration
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy of the weight-loss medicines it mailed to patients.| LAist